The development of clinical imaging techniques significantly improves diagnostic accuracy
and provides guidance for personalized treatment of individuals. However, every single …

Immunotherapy has dramatically changed prognosis for patients with malignant tumors.
However, as a non-immunogenic tumor, pancreatic ductal adenocarcinoma (PDAC) has a …

The use of conventional methods for the treatment of cancer, such as chemotherapy or
radiotherapy, and approaches such as brachytherapy in conjunction with the unique …

Following previously published systematic reviews on the diagnostic use of nanoparticles
(NPs), in this manuscript, we report published methods for radiolabeling nanoparticles with …

Prostate-specific membrane antigen (PSMA) and gastrin-releasing peptide receptor (GRPR)
have been used for diagnostic molecular imaging/therapy of prostate cancer (PCa). To …

The utilization of nanomaterials in biomedical applications has surged in recent years; yet,
the transition from research to practical implementation remains a great challenge. However …

Background Radiation nanomedicines are nanoparticles labeled with radionuclides that
emit α-or β-particles or Auger electrons for cancer treatment. We describe here our 15 years …

Nanoparticle (NP)-based solutions for oncotherapy promise an improved efficiency of the
anticancer response, as well as higher comfort for the patient. The current advancements in …

This study assessed the effectiveness of a trastuzumab-targeted 177Lu-labeled mesoporous
Carbon@ Silica nanostructure (DOTA@ TRA/MC@ Si) for HER2-positive breast cancer …

Background The tumor-specific immune responses, essential for removing residual lesions
and preventing tumor metastases, can be stimulated by tumor-associated antigens (TAAs) …